These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20530804)

  • 1. The costs and consequences of assisted reproductive technology: an economic perspective.
    Connolly MP; Hoorens S; Chambers GM;
    Hum Reprod Update; 2010; 16(6):603-13. PubMed ID: 20530804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptable cost for the patient and society.
    Chambers GM; Adamson GD; Eijkemans MJ
    Fertil Steril; 2013 Aug; 100(2):319-27. PubMed ID: 23905708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economics of assisted reproductive technologies.
    Ata B; Seli E
    Curr Opin Obstet Gynecol; 2010 Jun; 22(3):183-8. PubMed ID: 20125015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic implications of multiple pregnancy following ART.
    Chambers GM; Ledger W
    Semin Fetal Neonatal Med; 2014 Aug; 19(4):254-61. PubMed ID: 24933114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economics may not explain Hispanic underutilization of assisted reproductive technology services.
    Feinberg EC; Larsen FW; Wah RM; Alvero RJ; Armstrong AY
    Fertil Steril; 2007 Nov; 88(5):1439-41. PubMed ID: 17561005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insurance mandates and trends in infertility treatments.
    Henne MB; Bundorf MK
    Fertil Steril; 2008 Jan; 89(1):66-73. PubMed ID: 17482603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tubal reconstructive surgery in the era of assisted reproductive technologies.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S31-4. PubMed ID: 17055842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility.
    Meng MV; Greene KL; Turek PJ
    J Urol; 2005 Nov; 174(5):1926-31; discussion 1931. PubMed ID: 16217347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financing high-tech reproductive medical expenditures.
    Mueller MW
    Stanford Law Pol Rev; 1995; 6(2):113-20. PubMed ID: 12645603
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple births from assisted reproductive technologies: a challenge that must be met.
    Adamson D; Baker V
    Fertil Steril; 2004 Mar; 81(3):517-22, discussion 526. PubMed ID: 15037394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the Centers of Disease Control and Prevention. Use of assisted reproductive technology--United States, 1996 and 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(5):97-101. PubMed ID: 11892956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Babies born after ART treatment cost more than non-ART babies: a cost analysis of inpatient birth-admission costs of singleton and multiple gestation pregnancies.
    Chambers GM; Chapman MG; Grayson N; Shanahan M; Sullivan EA
    Hum Reprod; 2007 Dec; 22(12):3108-15. PubMed ID: 17905747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges.
    Ziebe S; Devroey P;
    Hum Reprod Update; 2008; 14(6):583-92. PubMed ID: 18786951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do couples refuse or discontinue ART?
    Dawson AA; Diedrich K; Felberbaum RE
    Arch Gynecol Obstet; 2005 Nov; 273(1):3-11. PubMed ID: 16080011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who should pay for assisted reproductive techniques? Answers from patients, professionals and the general public in Germany.
    Rauprich O; Berns E; Vollmann J
    Hum Reprod; 2010 May; 25(5):1225-33. PubMed ID: 20228390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stronger reduction of assisted reproduction technique treatment cycle numbers in economically weak geographical regions following the German healthcare modernization law in 2004.
    Griesinger G; Diedrich K; Altgassen C
    Hum Reprod; 2007 Nov; 22(11):3027-30. PubMed ID: 17884804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to assisted reproductive technology for cancer patients in Australia.
    McConnell R; Stankiewicz M; Koczwara B
    Asia Pac J Clin Oncol; 2011 Jun; 7(2):123-8. PubMed ID: 21585691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms.
    Connolly MP; Ledger W; Postma MJ
    Hum Fertil (Camb); 2010 Mar; 13(1):13-8. PubMed ID: 19903117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to artificial reproduction technology in the Nordic countries in 2004.
    Sol Olafsdottir H; Wikland M; Möller A
    Acta Obstet Gynecol Scand; 2009; 88(3):301-7. PubMed ID: 19241225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The International Committee Monitoring Assisted Reproductive Technologies (ICMART) glossary on ART terminology.
    Zegers-Hochschild F; Nygren KG; Adamson GD; de Mouzon J; Lancaster P; Mansour R; Sullivan E;
    Fertil Steril; 2006 Jul; 86(1):16-9. PubMed ID: 16762350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.